Teriparatide as a Chondroregenerative Therapy in OA

NCT03072147 PHASE2 COMPLETED

The purpose of this study is to evaluate teriparatide (TP) as a chondroregenerative therapy for human knee osteoarthritis (OA). The central hypothesis to be tested is that TP supports structural modification of the joint and improves biomarker, functional and patient-reported measures of knee OA.

Details

Lead sponsor	Christopher Ritchlin
Phase	PHASE2
Status	COMPLETED
Enrolment	76
Start date	Mon May 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Sep 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Knee Osteoarthritis
• Cartilage Degeneration

Interventions

• Teriparatide
• Placebo

Countries

United States